Sasiela; William J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sasiela; William J..The latest application filed is for "methods for reducing cardiovascular risk".

Company Profile

11.7.25

Sasiela; William J. - Tarrytown NY
SASIELA; William J. - Bloomingdale NJ
Sasiela; William J. - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For Reducing Cardiovascular Risk App 20220144969 - Bessac; Laurence ; et al.	2022-05-12
Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody Grant 11,306,155 - Baccara-Dinet , et al. April 19, 2	2022-04-19
Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody Grant 10,995,150 - Sasiela , et al. May 4, 2	2021-05-04
METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH) WITH AN ANTI-PCSK9 ANTIBODY App 20200216565 - Baccara-Dinet; Marie ; et al.	2020-07-09
Methods For Inhibiting Atherosclerosis By Administering An Inhibitor Of Pcsk9 App 20200071422 - Sasiela; William J. ; et al.	2020-03-05
Methods for Treating Patients with Familial Hypercholesterolemia App 20200061189 - PORDY; Robert C. ; et al.	2020-02-27
Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody Grant 10,544,232 - Baccara-Dinet , et al. Ja	2020-01-28
Dosing Regimens For Use With Pcsk9 Inhibitors App 20200024364 - Baccara-Dinet; Marie ; et al.	2020-01-23
Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9 Grant 10,494,442 - Sasiela , et al. De	2019-12-03
Methods for Treating Autosomal Dominant Hypercholesterolemia Associated with PCSK9 Gain-Of-Function Mutations App 20190330371 - SWERGOLD; Gary ; et al.	2019-10-31
Dosing regimens for use with PCSK9 inhibitors Grant 10,428,157 - Baccara-Dinet , et al. October 1, 2	2019-10-01
Methods For Reducing Cardiovascular Risk App 20190292273 - Hanotin; Corinne ; et al.	2019-09-26
Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9) Grant 10,111,953 - Swergold , et al. October 30, 2	2018-10-30
Methods for Treating Patients with Hypercholesterolemia that is not Adequately Controlled by Moderate-Dose Statin Therapy App 20180296672 - Pordy; Robert C. ; et al.	2018-10-18
Methods For Inhibiting Atherosclerosis By Administering An Inhibitor Of Pcsk9 App 20180244801 - Sasiela; William J. ; et al.	2018-08-30
Methods For Treating Patients With Familial Hypercholesterolemia App 20170312359 - Pordy; Robert C. ; et al.	2017-11-02
Methods for Treating Hypercholesterolemia and Reducing LDL-C Using Antibodies to PCSK9 App 20170296657 - Sleeman; Mark W. ; et al.	2017-10-19
Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9 Grant 9,724,411 - Sleeman , et al. August 8, 2	2017-08-08
METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH) App 20160137745 - Baccara-Dinet; Marie ; et al.	2016-05-19
Methods For Inhibiting Atherosclerosis By Administering An Inhibitor Of Pcsk9 App 20160115246 - Sasiela; William J. ; et al.	2016-04-28
Methods For Reducing Cardiovascular Risk App 20150284473 - Bessac; Laurence ; et al.	2015-10-08
Methods For Treating Patients With Hypercholesterolemia That Is Not Adequately Controlled By Moderate-dose Statin Therapy App 20150231236 - Pordy; Robert C. ; et al.	2015-08-20
Methods For Treating Obesity And Disorders Associated With Hyperlipidemia In A Mammal App 20150182515 - Sasiela; William J.	2015-07-02
Dosing Regimens For Use With Pcsk9 Inhibitors App 20150152191 - Baccara-Dinet; Marie ; et al.	2015-06-04
Use Of A Pcsk9 Inhibitor To Treat Hyperlipidemia App 20150140002 - Baccara-Dinet; Marie ; et al.	2015-05-21
Methods For Treating Autosomal Dominant Hypercholesterolemia Associated With Pcsk9 Gain-of-function Mutations App 20140356370 - SWERGOLD; Gary ; et al.	2014-12-04
Methods For Reducing Remnant Cholesterol And Other Lipoprotein Fractions By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin-9 (pcsk9) App 20140356371 - SWERGOLD; Gary ; et al.	2014-12-04
Methods For Treating Obesity And Disorders Associated With Hyperlipidemia In A Mammal App 20140148476 - Sasiela; William J.	2014-05-29
Methods for Treating Hypercholesterolemia and Reducing LDL-C Using Antibodies to PCSK9 App 20140099312 - Sleeman; Mark W. ; et al.	2014-04-10
Methods For Treating Hypercholesterolemia Using Antibodies To Pcsk9 App 20130064834 - SLEEMAN; Mark W. ; et al.	2013-03-14
Methods for Treating Obesity and Disorders Associated with Hyperlipidemia in a Mammal App 20120035204 - Sasiela; William J.	2012-02-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.